Reply to A. Ocaña et al and P.G. Tsoutsou et al

Affiliations

Comment

Sherene Loi. J Clin Oncol. 2015.

. 2015 Apr 10;33(11):1299-300.

doi: 10.1200/JCO.2014.59.9423. Epub 2015 Mar 9.

¹ Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia sherene.loi@petermac.org.

No abstract available

Comment on

Host antitumor immunity plays a role in the survival of patients with newly diagnosed triple-negative breast cancer.
Loi S. Loi S. J Clin Oncol. 2014 Sep 20;32(27):2935-7. doi: 10.1200/JCO.2014.56.7677. J Clin Oncol. 2014. PMID: 25071115 No abstract available.
Tumor-infiltrating lymphocytes in breast cancer: ready for prime time?
Ocaña A, Diez-Gónzález L, Adrover E, Fernández-Aramburo A, Pandiella A, Amir E. Ocaña A, et al. J Clin Oncol. 2015 Apr 10;33(11):1298-9. doi: 10.1200/JCO.2014.59.7286. Epub 2015 Mar 9. J Clin Oncol. 2015. PMID: 25753437 No abstract available.
Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?
Tsoutsou PG, Bourhis J, Coukos G. Tsoutsou PG, et al. J Clin Oncol. 2015 Apr 10;33(11):1297-8. doi: 10.1200/JCO.2014.59.2808. Epub 2015 Mar 9. J Clin Oncol. 2015. PMID: 25753438 No abstract available.